Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Psoriatic Arthritis Treatment Market

Psoriatic Arthritis Treatment Market Share

Report ID: GMI9864
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Psoriatic Arthritis Treatment Market Share

The competitive landscape of the market is characterized by intense competition, with companies focusing on research and development to introduce novel treatments and gain a competitive edge. Several key players offer a range of treatment options, including biologics, DMARDs, and corticosteroids. Also, strategic collaborations, mergers, and acquisitions are common strategies employed by players to strengthen their market position and expand their product portfolios in the rapidly evolving landscape of psoriatic arthritis treatment.

Psoriatic Arthritis Treatment Market Companies

Few of the prominent players operating in the psoriatic arthritis treatment industry include:

Abbvie Inc.
Amgen Inc.
Biogen
Bristol-Myers Squibb Company
Eli Lilly and Company
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Janssen Pharmaceutical Companies (Johnson and Johnson)
Merck KGA
Novartis AG
Pfizer Inc.
Samsung Bioepis Co., Ltd.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Industries Ltd.
UCB S.A

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global psoriatic arthritis treatment industry was valued at USD 10.2 billion in 2023 and is anticipated to register 9.7% CAGR between 2024 and 2032 due to increasing prevalence of psoriatic arthritis and growing awareness and diagnosis.

The injectable segment in the market held 57.7% revenue share in 2023 due to precise dosing, direct bloodstream delivery, and established efficacy.

Asia Pacific psoriatic arthritis treatment market size is expected to record 10.2% CAGR between 2024 and 2032 due to expanding population, product approvals coupled with increasing awareness and diagnosis rates of psoriatic arthritis.

Abbvie Inc., Amgen Inc., Biogen, Bristol-Myers Squibb Company, Eli Lilly and Company, Fujifilm Kyowa Kirin Biologics Co., Ltd., Janssen Pharmaceutical Companies (Johnson and Johnson), Merck KGA, and Novartis AG, among others.